rxstat › Shortages › Nepafenac

Nepafenac shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Nepafenac is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 2
Reports on file
8

Reports by product

Anticipated
ILEVRO
0.3% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02411393 · Shortage of an active ingredient.
Resolved
ILEVRO
0.3% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02411393 · ended May 17, 2023 · Disruption of the manufacture of the drug.
Resolved
ILEVRO
0.3% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02411393 · ended Oct 14, 2022 · Delay in shipping of the drug.
Resolved
NEVANAC
0.1% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02308983 · ended Apr 17, 2019 · Shortage of an active ingredient.
Resolved
ILEVRO
0.3% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02411393 · ended Dec 12, 2018 · Delay in shipping of the drug.
Resolved
NEVANAC
0.1% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02308983 · ended Jul 20, 2018 · Delay in shipping of the drug.
Resolved
NEVANAC
0.1% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02308983 · ended May 24, 2018 · Delay in shipping of the drug.
Resolved
NEVANAC
0.1% · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02308983 · ended Apr 10, 2018 · Delay in shipping of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Nepafenac to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Nepafenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).

Recent changes

Common questions

When will Nepafenac be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Nepafenac in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiinflammatory agents)

Partial shortageBromfenac1 of 2 reported products affected · est. return Mar 26, 2027Partial shortageDiclofenac5 of 34 reported products affected · est. return Sep 18, 2026Partial shortageDifluprednate1 of 1 reported products affected · est. return Jul 13, 2026Partial shortageKetorolac Tromethamine4 of 12 reported products affected · est. return Nov 6, 2026No current shortageDexamethasoneDiscontinuedFluorometholone0 of 1 reported products affected

All antiinflammatory agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.